Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Nov;76(5):1927–1931. doi: 10.1172/JCI112189

Membrane markers, target cell specificity, and sensitivity to biological response modifiers distinguish human natural cytotoxic from human natural killer cells.

M Rola-Pleszczynski, H Lieu, A K Sullivan, M Girard
PMCID: PMC424244  PMID: 2932473

Abstract

In the present report, we provide evidence for the distinct existence of a human natural cytotoxic (HNC) cell. This HNC cell can be identified by the monoclonal antibody HNC-1A3 and by the absence of the T10 antigen, other antigenic markers being shared, at least in part, with natural killer (NK) cells, T cells, or monocytes. In addition, the HNC cell preferentially kills the MA-160 target, the herpes simplex virus-1-infected MA-160 cell line, and the two human tumor cell lines HEp-2 and HF-2. It has weak lytic activity against the NK-sensitive K562 cell line or its relatively NK-resistant clone I subline. The cytotoxic activity of the HNC cell is not augmented by interferon but is markedly enhanced by interleukin 2 and by a measles-virus-induced factor (MVF). Furthermore, it is not inhibited by cyclosporin A (CsA), in contrast to NK cell cytotoxicity against the K562 target cell line which is augmented by interferon, inhibited by CsA, and not affected by MVF. These data suggest that spontaneously cytotoxic cells may belong to more than one subset of human lymphocytes, and that HNC cells may be defined in man using membrane markers, target cell specificity, and sensitivity to biological response modifiers.

Full text

PDF
1927

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abo T., Balch C. M. A differentiation antigen of human NK and K cells identified by a monoclonal antibody (HNK-1). J Immunol. 1981 Sep;127(3):1024–1029. [PubMed] [Google Scholar]
  2. Fitzgerald P. A., Evans R., Kirkpatrick D., Lopez C. Heterogeneity of human NK cells: comparison of effectors that lyse HSV-1-infected fibroblasts and K562 erythroleukemia targets. J Immunol. 1983 Apr;130(4):1663–1667. [PubMed] [Google Scholar]
  3. Henney C. S., Kuribayashi K., Kern D. E., Gillis S. Interleukin-2 augments natural killer cell activity. Nature. 1981 May 28;291(5813):335–338. doi: 10.1038/291335a0. [DOI] [PubMed] [Google Scholar]
  4. Introna M., Allavena P., Spreafico F., Mantovani A. Inhibition of human natural killer activity by cyclosporin A. Transplantation. 1981 Feb;31(2):113–116. doi: 10.1097/00007890-198102000-00004. [DOI] [PubMed] [Google Scholar]
  5. Kay H. D., Bonnard G. D., West W. H., Herberman R. B. A functional comparison of human Fc-receptor-bearing lymphocytes active in natural cytotoxicity and antibody-dependent cellular cytotoxicity. J Immunol. 1977 Jun;118(6):2058–2066. [PubMed] [Google Scholar]
  6. Landegren U., Ramstedt U., Axberg I., Orn A., Wigzell H. Cyclosporin a permits the distinction between specific T and NK activity generated in a human MLC. Int J Cancer. 1981 Dec;28(6):725–730. doi: 10.1002/ijc.2910280611. [DOI] [PubMed] [Google Scholar]
  7. Lattime E. C., Pecoraro G. A., Stutman O. The activity of natural cytotoxic cells is augmented by interleukin 2 and interleukin 3. J Exp Med. 1983 Mar 1;157(3):1070–1075. doi: 10.1084/jem.157.3.1070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Lopez C., Kirkpatrick D., Fitzgerald P. A., Ching C. Y., Pahwa R. N., Good R. A., Smithwick E. M. Studies of the cell lineage of the effector cells that spontaneously lyse HSV-1 infected fibroblasts (NK(HSV-1)). J Immunol. 1982 Aug;129(2):824–828. [PubMed] [Google Scholar]
  9. MacDougall S. L., Shustik C., Sullivan A. K. Target cell specificity of human natural killer (NK) cells. I. Development of an NK-resistant subline of K562. Cell Immunol. 1983 Feb 15;76(1):39–48. doi: 10.1016/0008-8749(83)90346-5. [DOI] [PubMed] [Google Scholar]
  10. Perussia B., Starr S., Abraham S., Fanning V., Trinchieri G. Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1. J Immunol. 1983 May;130(5):2133–2141. [PubMed] [Google Scholar]
  11. Rola-Pleszczynski M., Gagnon L., Sirois P. Leukotriene B4 augments human natural cytotoxic cell activity. Biochem Biophys Res Commun. 1983 Jun 15;113(2):531–537. doi: 10.1016/0006-291x(83)91758-8. [DOI] [PubMed] [Google Scholar]
  12. Rola-Pleszczynski M., Lieu H. Human natural cytotoxic lymphocytes: definition by a monoclonal antibody of a subset which kills an anchorage-dependent target cell line but not the K-562 cell line. Cell Immunol. 1983 Dec;82(2):326–333. doi: 10.1016/0008-8749(83)90166-1. [DOI] [PubMed] [Google Scholar]
  13. Saksela E., Timonen T., Cantell K. Human natural killer cell activity is augmented by interferon via recruitment of 'pre-NK' cells. Scand J Immunol. 1979;10(3):257–266. doi: 10.1111/j.1365-3083.1979.tb01348.x. [DOI] [PubMed] [Google Scholar]
  14. Stutman O., Paige C. J., Figarella E. F. Natural cytotoxic cells against solid tumors in mice. I. Strain and age distribution and target cell susceptibility. J Immunol. 1978 Nov;121(5):1819–1826. [PubMed] [Google Scholar]
  15. Timonen T., Ortaldo J. R., Herberman R. B. Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med. 1981 Mar 1;153(3):569–582. doi: 10.1084/jem.153.3.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Vánky F. T., Argov S. A., Einhorn S. A., Klein E. Role of alloantigens in natural killing. Allogeneic but not autologous tumor biopsy cells are sensitive for interferon-induced cytotoxicity of human blood lymphcoytes. J Exp Med. 1980 May 1;151(5):1151–1165. doi: 10.1084/jem.151.5.1151. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Yasukawa M., Zarling J. M. Autologous herpes simplex virus-infected cells are lysed by human natural killer cells. J Immunol. 1983 Oct;131(4):2011–2016. [PubMed] [Google Scholar]
  18. Zarling J. M., Clouse K. A., Biddison W. E., Kung P. C. Phenotypes of human natural killer cell populations detected with monoclonal antibodies. J Immunol. 1981 Dec;127(6):2575–2580. [PubMed] [Google Scholar]
  19. de Landazuri M. O., López-Botet M., Timonen T., Ortaldo J. R., Herberman R. B. Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines. J Immunol. 1981 Oct;127(4):1380–1383. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES